| |
1–6 pm
|
|
Conference Registration desk open |
| |
Rm: Red Wing
3rd Floor |
|
|
|
|
|
|
| |
|
|
|
|
1:30 pm |
|
Governing
Board Lunch (meeting will begin at two o’clock) |
| |
|
|
|
|
2–6 pm |
|
XS-1 HMORN
Board of Governors Lunch and
Meeting |
| |
Rm: Duluth
3rd Floor
Closed Meeting |
|
Agenda and materials will be
emailed to all board members prior to the meeting. |
|
|
|
|
|
|
|
|
| |
|
|
|
|
4–6 pm |
|
XS–2
Health Literacy, Kathleen Mazor |
| |
Rm:
Nicollet
2nd Floor
Open to All |
|
Open meeting on the CRN
Core project – “Health Literacy and Cancer Prevention:
Do Patients Understand What They Hear?” This meeting
will report on the progress of this project to date. It
is open to all interested parties; we will have
discussion and feedback. |
|
|
|
|
|
|
|
|
| |
|
|
|
| |
4–6 pm |
|
XS–3
Obesity Special Interest Group, Nancy Sherwood, Laura
Coleman |
| |
Rm:
Ramsey
2nd Floor
Open to All |
|
Established to foster
collaborative research to address questions that HMORN
obesity researchers are uniquely positioned to answer
given our access to integrated data systems (i.e.,
ability to link EMR, claims, and pharmacy data) as
well as the ability to conduct multi–level
observational and intervention studies at the level of
individuals, families, clinics, and health plan
policy. |
|
|
|
|
| |
|
|
|
|
|
|
Dinner
is on your own this evening |
|
|
|
|
| |
|
|
|
| |
6–8
pm |
|
XS–4
CRN Ovarian Cancer, Larissa Nekhlyudov |
| |
Rm: Board 2
3rd Floor
Limited
Audience |
|
The overall goal of
this project is to examine the use of combined
intravenous and intra–peritoneal chemotherapy for
advanced ovarian cancer in 8 CRN sites. This
ancillary meeting will focus on discussions of
preliminary analyses and manuscript writing. This is
a project team meeting open to members of the team.
Open to others though the value of attendance may be
limited. |
|
|
|
|
| |
|
|
|
| |
7–8:30 pm |
|
XS–5 CERT/DECIDE Distributed Network, Kim Lane |
| |
Rm: Board 1
3rd Floor
Closed
Meeting |
|
Project meeting for
the DEcIDE Distributed Research Network team |
| |
7 am–5 pm |
|
Conference Registration desk open |
| |
Rm:
Red Wing
3rd Floor |
|
|
| |
|
|
|
| |
7–8:30 am |
|
Continental Breakfast Available |
| |
Foyer D
3rd Floor |
|
|
|
|
|
|
|
|
|
7:30–9:30 am
|
|
XM–1 Writer’s
Workshop–How to Write Effective Specific
Aims–Kevin Lutz |
|
|
Rm: Hennepin
2nd Floor
Open to All |
|
A collaborative discussion
of grant writing focusing on the
specific aims section, an oft
overlooked section that is of paramount
importance. A mixture of experienced and
inexperienced investigators will help
illuminate the various perspectives,
challenges, and strategies to this
important aspect of grant writing.
Please contact
Kevin.Lutz@kpchr.org to receive
advance materials. |
|
|
|
|
|
8–9:30 am |
|
XM–2
CERT/DECIDE Distributed Network–Kim
Lane |
|
Rm: Board 1
3rd Floor
Closed
Meeting |
|
Project meeting for the
DEcIDE Distributed Research Network
team.
|
|
|
|
|
|
8–9:30 am |
|
XM–3
Biobanking, Ethics &
Procedures–Cathy McCarty, Eric
Larson |
|
Rm: Ramsey
2nd Floor
Open to
All |
|
To review the current
GWAS initiatives at the National
Human Genome Research Institute,
consider ELSI issues raised by the
research and ultimate clinical
application of the research, and the
perspectives of third party payers
in the personalized health care
movement. Confirmed speakers include
Dr. Jeff Struewing, the GWAS Project
Office at the National Human Genome
Research Institute, Dr. Wylie Burke,
an internationally renowned expert
in bioethics, Dr. Russ Kuzel, the
Chief Medical Officer at Security
Health Plan in Marshfield and two
HMORN investigators involved in
large–scale biobanking efforts, Drs.
Cathy Schaeffer and Bob Davis.
In addition to the formal
presentations, there will be a 30
minute panel discussion at the end
of the session. |
|
|
|
|
|
8–9:30 am |
|
XM–4 CRN Her2
Diffusion–Diana Buist |
|
Rm:
Directors
Row 1
Closed
Meeting |
|
Her2neu working group
for the Her2 grant. Open to NCI,
ACS and invited individuals only. |
| |
|
|
|
| |
8–9 am |
|
U.S. Congressman Dave Obey,
Wisconsin’s Seventh District,
chair of the House
Appropriations Committee
|
|
|
|
[Invited–Monday
morning ancillary meetings may
be rescheduled if Congressman
Obey is able to attend] |
|
|
|
|
| |
8:30–10 am |
|
XM–5
Cancer Prevention Index
Study–Tom Vogt |
|
Rm:
LaSalle
2nd Floor
Closed
Meeting
|
|
This meeting is
limited to investigators and
staff of the Cancer Prevention
Index pilot study. A
representative from the four
sites who were a part of the
original proposal but were
dropped when it was reduced to a
pilot is welcome to attend as
well. Participating sites are:
KP Hawaii and KP Portland, and
all CPI staff and investigators
at HMORN are urged to attend.
The other sites from which we
welcome representatives are: KP
Southern Calif., KP Colorado,
Harvard Pilgrim, and
HealthPartners. This meeting
will focus on progress and plans
for completing the pilot and for
generating a larger R01 from the
results of the pilot. |
|
|
|
|
|
8:30–10 am |
|
XM–6 STD Research
SIG–Delia Scholes |
|
Rm:
Carver
2nd Floor
Open to All |
|
Sexually
transmitted diseases (STD/HIV)
are a focus of national
attention, both for their
high––and in some instances
increasing––rates and their
potential for prevention and
control. The purpose of this
SIG will be to explore HMORN–based
collaborative research
opportunities in this area of
work. |
|
|
|
|
|
9–11:30
am |
|
Poster
Session 1 Set-Up |
|
Salon C
3rd Floor |
|
|
|
|
|
|
|
| |
9–10:30 am |
|
XM–7 Looking
at Consent through a New
Lens: The PRISM
Readability
Toolkit–Jessica Ridpath |
| |
Rm: Marquette
2nd Floor
Open to All |
|
This
interactive workshop will
provide an overview of
strategies, tools, and
resources to help
attendees create
participant–centered study
materials that are easy to
read and understand.
Attendees will receive the
PRISM Readability Toolkit,
a product of Group
Health's ongoing
readability initiative
that has received
widespread attention and
uptake in the research and
health care communities.
Open to all, but
especially relevant to
anyone involved in the
development of consent
forms and other study
materials. |
| |
|
|
|
| |
9:30–11:30
am |
|
XM–8 CVRN
Steering Committee–Alan
Go |
|
|
Rm: Hennepin
2nd Floor
Closed Meeting |
|
This is a meeting of the
HMORN Cardiovascular
Research Network (CVRN)
Steering Committee and
is limited to members of
the Steering Committee,
CVRN project
investigators, and
invited NIH colleagues. |
|
|
|
|
|
9:30–11:30
am |
|
XM–9 CRN
MENU Study
Wrap–Christine Cole
Johnson, Gwen
Alexander |
|
Rm: Board
1
3rd Floor
Closed
Meeting |
|
The MENU
meeting at the HMORN
conference will
provide overview of
results of the aMENU
study, and discussion
of future research
collaborations in the
wake of the MENU
findings. Open to MENU
study team only. |
|
|
|
|
|
9:30–11:30 am |
|
XM–10
CRN DCIS
Project–Laurel Habel |
|
Rm:
Nicollet
2nd Floor
Closed
Meeting |
|
Clinical
and Pathologic
Predictors for
Recurrence after
DCIS Investigators
Meeting. The goal of
the study is to
identify clinical
and pathological
factors that can be
used to accurately
identify DCIS women
at high and low risk
for recurrence. |
|
|
|
|
|
9:30–11:30 am |
|
XM–11
VDW Training–Gene
Hart, Jennifer
Ellis |
|
Rm:
Ramsey
2nd Floor
Open to All |
|
This
is an introduction
to the HMORN's
Virtual Data
Warehouse (VDW)
aimed at
Investigators. We
will demonstrate
how the VDW has
been used and
demonstrate how it
can be used in the
future. |
|
|
|
|
|
| |
10:30–11:30 am |
|
XM–12
Effort
Reporting–Barbara
Richard, Beverly
Prawalsky |
| |
Rm:
Marquette
2nd Floor
Open to All |
|
This session
will present an
overview of
audit risks
related to all
the HMORN
members who
accept Federal
funds and are
required to
report and
certify Time and
Effort according
to OMB A–122
guidelines. We
will focus on
commonalities
among all sites,
how recent audit
findings and
publications
relate to our
particular
situations, and
leave room for
an open
discussion of
encountered
problems and
solutions. Open
to those who are
involved with,
or concerned
about financial
research
compliance
risks. |
| |
|
|
|
| |
11:30
am–12:15 pm |
|
Lunch |
|
|
Rm:
Salon A&B
3rd Floor |
|
|
|
|
|
|
|
| |
Noon |
|
Welcome to
the 2008
HMORN Annual
Conference
Andy Nelson
and Bob
Greenlee |
| |
|
|
|
| |
12:15–1:30
pm |
|
Plenary I:
Clinical
Leadership
Panel
George
Isham, MD,
MS;
HealthPartners
|
|
|
Rm:
Salon
A&B
3rd
Floor |
|
A close
partnership
between
care
delivery
and
research
organizations
has the
potential
to
provide
essential
elements
needed
to
optimize
health
and
health
care.
This
clinical
leadership
panel
will
identify
the
value,
opportunities
and
challenges
of those
close
partnerships
between
three
HMORN
care
delivery
and
research
organizations.
The
objectives
of this
plenary
session
are:
-
Identify
the
important
facets
of
partnership
that
bring
value
to
care
delivery
and
research.
-
Pinpoint
the
critical
alignments
of
care
delivery
and
research
that
are
needed
to
fulfill
the
promised
value
between
clinical
and
research
organizations.
-
Recognize
the
challenges
that
clinical
and
research
organizations
need
to
address.
|
|
|
|
|
Participants:
Thomas
Kottke,
MD;
HealthPartners
Research
Foundation
Brian
Rank,
MD;
HealthPartners
Medical
Group
Doug
Reding,
MD,
MPH;
Marshfield
Clinic
Mark
Selna,
MD;
Geisinger
Clinic |
|
|
|
|
|
|
|
|
|
|
|
|
1:45–3:15
pm |
|
C–A1
Research
Administration–Barry
Miller,
Kate
Rardin |
|
|
Rm:
Marquette
2nd
Floor |
|
Addresses
ways
administrative
support
can
help
advance
collaborative
HMORN
research. |
|
|
|
|
Ellen
Deitch,
Center
for
Health
Research,
Kaiser
Permanente
Robin
Hudson,
Center
for
Health
Research,
Southeast,
Kaiser
Tim
O'Bar,
Center
for
Health
Studies,
Group
Health
Ben
Prince,
Fallon
Clinic
Barbara
Richard,
Harvard
Pilgrim
Paul
Steele,
Center
for
Health
Research,
Kaiser
Permanente |
|
|
|
|
|
1:45–3:15 pm |
|
C–A2 Pharmacoepidemiology–Cathy McCarty, Susan Andrade |
|
Rm: Ramsey
2nd Floor |
|
Pharmacoepidemiology is the study of the distribution and determinants of drug–related events in populations and the application of this study to efficacious drug treatment. This session explores a wide range of issues in pharmacoepidemiology studies. |
|
|
|
|
|
|
|
Long-term persistence with statins: A population-based study among Health Maintenance Organization enrollees in Israel
Gabriel Chodick, PhD; Maccabi Healthcare Services, Sackler Faculty of Medicine, Tel Aviv University Breast Cancer Recurrence Risk in Relation to Antidepressant Use after Diagnosis
Jessica Chubak, PhD; Group Health Center for Health Studies Development
Implementation & Evaluation of an Educational Curriculum on Pharmaceutical Marketing & Prescribing
David W. Price, MD; CPMG Dept of Education/KP Colorado Inst Health Research
Adherence to Urate Lowering Medications for the Treatment of Chronic Gout
Leslie R. Harrold, MD, MPH; Meyers Primary Care Institute/Fallon
Pneumonia Risk among COPD Patients Using Fluticasone/Salmeterol Versus Other Inhaled Steroids and Bronchodilators Alone
Michael Schum, PhD; Lovelace Clinic Foundation
|
HealthPartners
Research Foundation, Minneapolis, MN